Jefferies Downgrades JCR Pharmaceuticals to Hold From Buy, Adjusts Price Target to 1,200 Yen From 1,800 Yen
Jefferies Downgrades JCR Pharmaceuticals to Hold From Buy, Adjusts Price Target to 1,200 Yen From 1,800 Yen
傑富瑞將JCR Pharmicals的評級從買入下調至持有,將目標股價從1,800日元調整至1,200日元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊